These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 20920142

  • 1. Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease.
    Hoshino M, Ohtawa J.
    Respirology; 2011 Jan; 16(1):95-101. PubMed ID: 20920142
    [Abstract] [Full Text] [Related]

  • 2. Effects of tiotropium and salmeterol/fluticasone propionate on airway wall thickness in chronic obstructive pulmonary disease.
    Hoshino M, Ohtawa J.
    Respiration; 2013 Jan; 86(4):280-7. PubMed ID: 23880883
    [Abstract] [Full Text] [Related]

  • 3. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.
    Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
    [Abstract] [Full Text] [Related]

  • 4. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
    Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group.
    Respir Med; 2012 Mar; 106(3):382-9. PubMed ID: 21975275
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
    Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE.
    Respir Med; 2012 Jan; 106(1):91-101. PubMed ID: 22040533
    [Abstract] [Full Text] [Related]

  • 7. Predictive factors for evaluation of response to fluticasone propionate/salmeterol combination in severe COPD.
    Tonnel AB, Tillie-Leblond I, Attali V, Bavelele Z, Lagrange O.
    Respir Med; 2011 Feb; 105(2):250-8. PubMed ID: 20702076
    [Abstract] [Full Text] [Related]

  • 8. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [Abstract] [Full Text] [Related]

  • 9. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen A.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):105; author reply 106-7. PubMed ID: 18565963
    [No Abstract] [Full Text] [Related]

  • 10. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun 01; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

  • 11. Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPD.
    Dalal AA, Candrilli SD, Davis KL.
    Manag Care; 2011 Aug 01; 20(8):46-50, 53-5. PubMed ID: 21887993
    [Abstract] [Full Text] [Related]

  • 12. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.
    Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Dalal A, Su Z, Sampalis JS.
    Curr Med Res Opin; 2014 Jul 01; 30(7):1427-36. PubMed ID: 24666181
    [Abstract] [Full Text] [Related]

  • 13. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
    Cazzola M, Andò F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, D'Amato M.
    Pulm Pharmacol Ther; 2007 Jul 01; 20(5):556-61. PubMed ID: 16914336
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD.
    Perng DW, Tao CW, Su KC, Tsai CC, Liu LY, Lee YC.
    Eur Respir J; 2009 Apr 01; 33(4):778-84. PubMed ID: 19129278
    [Abstract] [Full Text] [Related]

  • 15. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
    Niewoehner DE.
    COPD; 2009 Feb 01; 6(1):1-3. PubMed ID: 19229702
    [Abstract] [Full Text] [Related]

  • 16. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
    Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.
    Ann Intern Med; 2007 Apr 17; 146(8):545-55. PubMed ID: 17310045
    [Abstract] [Full Text] [Related]

  • 17. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 17; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 18. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T, Haggart K, Lee DK, Lipworth BJ.
    Respir Med; 2007 Jun 17; 101(6):1218-28. PubMed ID: 17178217
    [Abstract] [Full Text] [Related]

  • 19. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.
    Respir Med; 2008 Aug 17; 102(8):1099-108. PubMed ID: 18614347
    [Abstract] [Full Text] [Related]

  • 20. Benefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: a meta-analysis.
    Liu Y, Shi H, Sun X, Zhang D, Zhang Y, Yang K, Mi L, Li M.
    Eur J Intern Med; 2014 Jun 17; 25(5):491-5. PubMed ID: 24816076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.